# Quality Assurance Report

---

# Identity

| Field | Value |
|-------|-------|
| QA Report ID | QA-PP-0145 |
| Population Package | PP-0145 |
| Version | 1.0.0 |
| Review Status | PASS |

---

# Layer 1 — Content QA

| Criterion | Result |
|-----------|--------|
| Single educational question | PASS |
| Scope respected | PASS |
| Complete coverage | PASS |
| Internal consistency | PASS |
| Logical organization | PASS |
| Knowledge blocks complete | PASS |
| No overlap with adjacent Population Packages | PASS |
| Atomic Knowledge Principle preserved | PASS |

---

# Layer 2 — Clinical QA

| Criterion | Result |
|-----------|--------|
| Scientifically accurate | PASS |
| Consistent with ACMG | PASS |
| Consistent with AMP | PASS |
| Consistent with ClinGen SVI | PASS |
| Consistent with ClinGen VCEP implementation principles | PASS |
| Appropriate explanation of BS1 | PASS |
| Appropriate explanation of allele frequency | PASS |
| Appropriate explanation of "greater than expected" | PASS |
| Disease-specific nature appropriately represented | PASS |
| No universal BS1 threshold implied | PASS |
| Population-data context appropriately acknowledged | PASS |
| Appropriate distinction between BS1 and BA1 | PASS |
| No unsupported clinical claim | PASS |
| No unsafe medical advice | PASS |

---

# Layer 3 — Educational QA

| Criterion | Result |
|-----------|--------|
| Plain language | PASS |
| Appropriate for patients | PASS |
| Learning objectives satisfied | PASS |
| Common misconceptions addressed | PASS |
| "Common = automatically benign" misconception corrected | PASS |
| Disease-specific nature explained | PASS |
| Numerical threshold overgeneralization avoided | PASS |
| Technical population methodology appropriately deferred | PASS |
| BS evidence strength clearly explained | PASS |

---

# Layer 4 — Governance QA

| Criterion | Result |
|-----------|--------|
| CKO completed | PASS |
| Knowledge Passport completed | PASS |
| Evidence Package completed | PASS |
| Evidence traceability complete | PASS |
| Scope maintained | PASS |
| Knowledge Graph complete | PASS |
| Versioning complete | PASS |
| Repository compliant | PASS |
| Disease-specific implementation boundary encoded | PASS |

---

# Clinical Safety Review

| Item | Result |
|------|--------|
| No unsafe medical advice | PASS |
| No universal frequency cutoff presented | PASS |
| No automatic benign classification implied | PASS |
| Disease context emphasized | PASS |
| Population context acknowledged | PASS |
| Technical frequency methodology appropriately deferred | PASS |
| BS1 not confused with BA1 | PASS |
| Expert interpretation remains necessary | PASS |
| No treatment recommendations | PASS |

---

# Educational Boundary Review

The Population Package remains within the predefined educational boundary.

### Included

- BS1 definition
- Allele frequency
- Greater-than-expected principle
- Disease-specific interpretation
- Population context
- BS1 versus other benign evidence
- Patient implications

### Excluded

- Numerical gene-specific thresholds
- gnomAD technical methodology
- PopMax / GrpMax / FAF
- Whiffin/Ware calculator
- Founder-effect calculations
- Detailed ancestry methodology
- BA1 implementation
- Bayesian framework
- Evidence-combination rules
- Gene-specific ClinGen VCEP specifications
- Laboratory workflow
- Treatment recommendations

The **Atomic Knowledge Principle** has been fully preserved.

---

# Runtime Safety Review

The package establishes the following safety boundary:

> **BS1 is not a universal numerical cutoff.**

The Safe Medical AI System must therefore avoid statements such as:

- "A variant above X% is always BS1."
- "Any common variant is benign."
- "Population frequency alone proves a variant is harmless."

Instead, the system should communicate that:

- BS1 depends on whether the frequency is greater than expected **for the specific disorder**;
- disease-specific ClinGen specifications should be followed when available;
- population frequency is one component of structured variant interpretation.

---

# Final Quality Decision

## PASS

PP-0145 satisfies the locked **Gold Population Package Specification v1.0**.

Approved as the official Population Package for:

> **PP-0145 — BS1 (Allele Frequency Is Greater Than Expected for a Disorder)**

---

# Reviewer Notes

This Population Package intentionally avoids giving a universal BS1 frequency threshold.

That boundary is clinically important because current ClinGen Expert Panel specifications demonstrate substantial variation in BS1 thresholds between disorders and genes. Some specifications explicitly derive thresholds from disease prevalence, penetrance, allelic heterogeneity and genetic heterogeneity, while others impose population-data quality and ancestry requirements. :contentReference[oaicite:9]{index=9}

The package therefore teaches the **principle** of BS1 without converting a disease-specific clinical interpretation rule into a simplistic population-frequency number.

The package maintains strict adherence to the **Atomic Knowledge Principle** and the locked Gold Workflow.